These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 10528114)

  • 1. Apolipoprotein E and beta-amyloid levels in the hippocampus and frontal cortex of Alzheimer's disease subjects are disease-related and apolipoprotein E genotype dependent.
    Beffert U; Cohn JS; Petit-Turcotte C; Tremblay M; Aumont N; Ramassamy C; Davignon J; Poirier J
    Brain Res; 1999 Oct; 843(1-2):87-94. PubMed ID: 10528114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genotype-related differences of hippocampal apolipoprotein E levels only in early stages of neuropathological changes in Alzheimer's disease.
    Glöckner F; Meske V; Ohm TG
    Neuroscience; 2002; 114(4):1103-14. PubMed ID: 12379263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic associations between cathepsin D exon 2 C-->T polymorphism and Alzheimer's disease, and pathological correlations with genotype.
    Davidson Y; Gibbons L; Pritchard A; Hardicre J; Wren J; Tian J; Shi J; Stopford C; Julien C; Thompson J; Payton A; Thaker U; Hayes AJ; Iwatsubo T; Pickering-Brown SM; Pendleton N; Horan MA; Burns A; Purandare N; Lendon CL; Neary D; Snowden JS; Mann DM
    J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):515-7. PubMed ID: 16543533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein E genotype and deposits of Abeta40 and Abeta42 in Alzheimer disease.
    McNamara MJ; Gomez-Isla T; Hyman BT
    Arch Neurol; 1998 Jul; 55(7):1001-4. PubMed ID: 9678319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of apolipoprotein E in Alzheimer's disease and its significance].
    He SR; Liu DG; Wang S; Xia YJ
    Zhonghua Bing Li Xue Za Zhi; 2005 Sep; 34(9):556-60. PubMed ID: 16468304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alzheimer beta amyloid deposition enhanced by apoE epsilon4 gene precedes neurofibrillary pathology in the frontal association cortex of nondemented senior subjects.
    Yamaguchi H; Sugihara S; Ogawa A; Oshima N; Ihara Y
    J Neuropathol Exp Neurol; 2001 Jul; 60(7):731-9. PubMed ID: 11444802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein E genotype regulates amyloid-beta cytotoxicity.
    Wilhelmus MM; Otte-Höller I; Davis J; Van Nostrand WE; de Waal RM; Verbeek MM
    J Neurosci; 2005 Apr; 25(14):3621-7. PubMed ID: 15814793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein C-I expression in the brain in Alzheimer's disease.
    Petit-Turcotte C; Stohl SM; Beffert U; Cohn JS; Aumont N; Tremblay M; Dea D; Yang L; Poirier J; Shachter NS
    Neurobiol Dis; 2001 Dec; 8(6):953-63. PubMed ID: 11741391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deciphering ApoE Genotype-Driven Proteomic and Lipidomic Alterations in Alzheimer's Disease Across Distinct Brain Regions.
    Odenkirk MT; Zheng X; Kyle JE; Stratton KG; Nicora CD; Bloodsworth KJ; Mclean CA; Masters CL; Monroe ME; Doecke JD; Smith RD; Burnum-Johnson KE; Roberts BR; Baker ES
    J Proteome Res; 2024 Aug; 23(8):2970-2985. PubMed ID: 38236019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. APOE and AβPP gene variation in cortical and cerebrovascular amyloid-β pathology and Alzheimer's disease: a population-based analysis.
    Peuralinna T; Tanskanen M; Mäkelä M; Polvikoski T; Paetau A; Kalimo H; Sulkava R; Hardy J; Lai SL; Arepalli S; Hernandez D; Traynor BJ; Singleton A; Tienari PJ; Myllykangas L
    J Alzheimers Dis; 2011; 26(2):377-85. PubMed ID: 21654062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue transglutaminase-catalysed cross-linking induces Apolipoprotein E multimers inhibiting Apolipoprotein E's protective effects towards amyloid-beta-induced toxicity.
    de Jager M; Drukarch B; Hofstee M; Brevé J; Jongenelen CA; Bol JG; Wilhelmus MM
    J Neurochem; 2015 Sep; 134(6):1116-28. PubMed ID: 26088696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The APOE Gene is Differentially Methylated in Alzheimer's Disease.
    Foraker J; Millard SP; Leong L; Thomson Z; Chen S; Keene CD; Bekris LM; Yu CE
    J Alzheimers Dis; 2015; 48(3):745-55. PubMed ID: 26402071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein E-epsilon 2 and Alzheimer's disease: genotype influences pathologic phenotype.
    Lippa CF; Smith TW; Saunders AM; Hulette C; Pulaski-Salo D; Roses AD
    Neurology; 1997 Feb; 48(2):515-9. PubMed ID: 9040748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between apolipoprotein E e4 allele and arteriosclerosis, cerebral amyloid angiopathy, and cerebral white matter damage in Alzheimer's disease.
    Tian J; Shi J; Bailey K; Lendon CL; Pickering-Brown SM; Mann DM
    J Neurol Neurosurg Psychiatry; 2004 May; 75(5):696-9. PubMed ID: 15090562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Multi-Cohort Study of ApoE ɛ4 and Amyloid-β Effects on the Hippocampus in Alzheimer's Disease.
    Khan W; Giampietro V; Banaschewski T; Barker GJ; Bokde AL; Büchel C; Conrod P; Flor H; Frouin V; Garavan H; Gowland P; Heinz A; Ittermann B; Lemaître H; Nees F; Paus T; Pausova Z; Rietschel M; Smolka MN; Ströhle A; Gallinat J; Vellas B; Soininen H; Kloszewska I; Tsolaki M; Mecocci P; Spenger C; Villemagne VL; Masters CL; Muehlboeck JS; Bäckman L; Fratiglioni L; Kalpouzos G; Wahlund LO; Schumann G; Lovestone S; Williams SC; Westman E; Simmons A; ; ;
    J Alzheimers Dis; 2017; 56(3):1159-1174. PubMed ID: 28157104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cortical β-amyloid burden, gray matter, and memory in adults at varying APOE ε4 risk for Alzheimer's disease.
    Mecca AP; Barcelos NM; Wang S; Brück A; Nabulsi N; Planeta-Wilson B; Nadelmann J; Benincasa AL; Ropchan J; Huang Y; Gelernter J; Van Ness PH; Carson RE; van Dyck CH
    Neurobiol Aging; 2018 Jan; 61():207-214. PubMed ID: 29111487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
    Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
    JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.
    Premkumar DR; Cohen DL; Hedera P; Friedland RP; Kalaria RN
    Am J Pathol; 1996 Jun; 148(6):2083-95. PubMed ID: 8669492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opposite roles of apolipoprotein E in normal brains and in Alzheimer's disease.
    Russo C; Angelini G; Dapino D; Piccini A; Piombo G; Schettini G; Chen S; Teller JK; Zaccheo D; Gambetti P; Tabaton M
    Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15598-602. PubMed ID: 9861015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profiles of β-Amyloid Peptides and Key Secretases in Brain Autopsy Samples Differ with Sex and APOE ε4 Status: Impact for Risk and Progression of Alzheimer Disease.
    Nyarko JNK; Quartey MO; Pennington PR; Heistad RM; Dea D; Poirier J; Baker GB; Mousseau DD
    Neuroscience; 2018 Mar; 373():20-36. PubMed ID: 29331531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.